nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—CYP2B6—Tamoxifen—pancreatic cancer	0.0511	0.0629	CbGbCtD
Enzalutamide—ALB—Erlotinib—pancreatic cancer	0.0426	0.0524	CbGbCtD
Enzalutamide—CYP3A5—Tamoxifen—pancreatic cancer	0.0403	0.0495	CbGbCtD
Enzalutamide—CYP2B6—Irinotecan—pancreatic cancer	0.0393	0.0483	CbGbCtD
Enzalutamide—CYP2C8—Tamoxifen—pancreatic cancer	0.0387	0.0476	CbGbCtD
Enzalutamide—ALB—Irinotecan—pancreatic cancer	0.0385	0.0473	CbGbCtD
Enzalutamide—ALB—Fluorouracil—pancreatic cancer	0.0369	0.0454	CbGbCtD
Enzalutamide—CYP3A5—Erlotinib—pancreatic cancer	0.0342	0.0421	CbGbCtD
Enzalutamide—CYP2C8—Erlotinib—pancreatic cancer	0.0329	0.0405	CbGbCtD
Enzalutamide—CYP2C19—Tamoxifen—pancreatic cancer	0.0325	0.04	CbGbCtD
Enzalutamide—CYP3A5—Irinotecan—pancreatic cancer	0.0309	0.038	CbGbCtD
Enzalutamide—CYP2C8—Fluorouracil—pancreatic cancer	0.0285	0.0351	CbGbCtD
Enzalutamide—CYP2C9—Tamoxifen—pancreatic cancer	0.027	0.0332	CbGbCtD
Enzalutamide—ABCB1—Tamoxifen—pancreatic cancer	0.0262	0.0322	CbGbCtD
Enzalutamide—CYP2D6—Tamoxifen—pancreatic cancer	0.0247	0.0304	CbGbCtD
Enzalutamide—CYP3A5—Docetaxel—pancreatic cancer	0.0227	0.0279	CbGbCtD
Enzalutamide—ABCB1—Gemcitabine—pancreatic cancer	0.0226	0.0278	CbGbCtD
Enzalutamide—CYP3A5—Sunitinib—pancreatic cancer	0.0226	0.0278	CbGbCtD
Enzalutamide—ABCB1—Erlotinib—pancreatic cancer	0.0223	0.0274	CbGbCtD
Enzalutamide—CYP2B6—Doxorubicin—pancreatic cancer	0.0214	0.0264	CbGbCtD
Enzalutamide—CYP2D6—Erlotinib—pancreatic cancer	0.021	0.0258	CbGbCtD
Enzalutamide—ABCB1—Irinotecan—pancreatic cancer	0.0201	0.0248	CbGbCtD
Enzalutamide—CYP2C9—Fluorouracil—pancreatic cancer	0.0199	0.0245	CbGbCtD
Enzalutamide—CYP3A4—Tamoxifen—pancreatic cancer	0.0157	0.0193	CbGbCtD
Enzalutamide—ABCB1—Docetaxel—pancreatic cancer	0.0147	0.0181	CbGbCtD
Enzalutamide—ABCB1—Sunitinib—pancreatic cancer	0.0147	0.0181	CbGbCtD
Enzalutamide—CYP3A4—Erlotinib—pancreatic cancer	0.0134	0.0164	CbGbCtD
Enzalutamide—CYP3A4—Irinotecan—pancreatic cancer	0.0121	0.0148	CbGbCtD
Enzalutamide—ABCB1—Doxorubicin—pancreatic cancer	0.011	0.0135	CbGbCtD
Enzalutamide—CYP2D6—Doxorubicin—pancreatic cancer	0.0104	0.0127	CbGbCtD
Enzalutamide—CYP3A4—Docetaxel—pancreatic cancer	0.00884	0.0109	CbGbCtD
Enzalutamide—CYP3A4—Sunitinib—pancreatic cancer	0.0088	0.0108	CbGbCtD
Enzalutamide—CYP3A4—Doxorubicin—pancreatic cancer	0.00659	0.0081	CbGbCtD
Enzalutamide—Hot flush—Docetaxel—pancreatic cancer	0.000639	0.00363	CcSEcCtD
Enzalutamide—Infestation NOS—Fluorouracil—pancreatic cancer	0.000639	0.00362	CcSEcCtD
Enzalutamide—Infestation—Fluorouracil—pancreatic cancer	0.000639	0.00362	CcSEcCtD
Enzalutamide—Hypertension—Tamoxifen—pancreatic cancer	0.000638	0.00362	CcSEcCtD
Enzalutamide—Mental disorder—Sunitinib—pancreatic cancer	0.000637	0.00361	CcSEcCtD
Enzalutamide—Menopausal symptoms—Docetaxel—pancreatic cancer	0.000634	0.0036	CcSEcCtD
Enzalutamide—Arthralgia—Tamoxifen—pancreatic cancer	0.000629	0.00357	CcSEcCtD
Enzalutamide—Anxiety—Tamoxifen—pancreatic cancer	0.000627	0.00356	CcSEcCtD
Enzalutamide—Arthralgia—Erlotinib—pancreatic cancer	0.000622	0.00353	CcSEcCtD
Enzalutamide—Anxiety—Erlotinib—pancreatic cancer	0.00062	0.00352	CcSEcCtD
Enzalutamide—Haematuria—Gemcitabine—pancreatic cancer	0.000619	0.00351	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000618	0.00351	CcSEcCtD
Enzalutamide—Back pain—Sunitinib—pancreatic cancer	0.000612	0.00347	CcSEcCtD
Enzalutamide—Epistaxis—Fluorouracil—pancreatic cancer	0.000602	0.00342	CcSEcCtD
Enzalutamide—Rhinitis—Irinotecan—pancreatic cancer	0.0006	0.0034	CcSEcCtD
Enzalutamide—Sinusitis—Fluorouracil—pancreatic cancer	0.000599	0.0034	CcSEcCtD
Enzalutamide—Infection—Tamoxifen—pancreatic cancer	0.000599	0.0034	CcSEcCtD
Enzalutamide—Infection—Erlotinib—pancreatic cancer	0.000593	0.00336	CcSEcCtD
Enzalutamide—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00059	0.00335	CcSEcCtD
Enzalutamide—Connective tissue disorder—Irinotecan—pancreatic cancer	0.000588	0.00334	CcSEcCtD
Enzalutamide—Nervous system disorder—Erlotinib—pancreatic cancer	0.000585	0.00332	CcSEcCtD
Enzalutamide—Rhinitis—Gemcitabine—pancreatic cancer	0.000585	0.00332	CcSEcCtD
Enzalutamide—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000584	0.00331	CcSEcCtD
Enzalutamide—Skin disorder—Erlotinib—pancreatic cancer	0.000579	0.00329	CcSEcCtD
Enzalutamide—Pharyngitis—Gemcitabine—pancreatic cancer	0.000579	0.00328	CcSEcCtD
Enzalutamide—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.000576	0.00327	CcSEcCtD
Enzalutamide—Rhinitis—Fluorouracil—pancreatic cancer	0.000575	0.00326	CcSEcCtD
Enzalutamide—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000574	0.00326	CcSEcCtD
Enzalutamide—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000573	0.00325	CcSEcCtD
Enzalutamide—Urethral disorder—Gemcitabine—pancreatic cancer	0.000572	0.00324	CcSEcCtD
Enzalutamide—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.00057	0.00324	CcSEcCtD
Enzalutamide—Pharyngitis—Fluorouracil—pancreatic cancer	0.000569	0.00323	CcSEcCtD
Enzalutamide—Leukopenia—Sunitinib—pancreatic cancer	0.000566	0.00321	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Epirubicin—pancreatic cancer	0.000563	0.00319	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000549	0.00312	CcSEcCtD
Enzalutamide—Dry skin—Docetaxel—pancreatic cancer	0.000548	0.00311	CcSEcCtD
Enzalutamide—Convulsion—Sunitinib—pancreatic cancer	0.000548	0.00311	CcSEcCtD
Enzalutamide—Hypertension—Sunitinib—pancreatic cancer	0.000546	0.0031	CcSEcCtD
Enzalutamide—Insomnia—Tamoxifen—pancreatic cancer	0.000545	0.00309	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000543	0.00308	CcSEcCtD
Enzalutamide—Angiopathy—Irinotecan—pancreatic cancer	0.000543	0.00308	CcSEcCtD
Enzalutamide—Paraesthesia—Tamoxifen—pancreatic cancer	0.000541	0.00307	CcSEcCtD
Enzalutamide—Insomnia—Erlotinib—pancreatic cancer	0.000539	0.00306	CcSEcCtD
Enzalutamide—Arthralgia—Sunitinib—pancreatic cancer	0.000539	0.00306	CcSEcCtD
Enzalutamide—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000535	0.00303	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000535	0.00303	CcSEcCtD
Enzalutamide—Angiopathy—Gemcitabine—pancreatic cancer	0.000529	0.003	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Doxorubicin—pancreatic cancer	0.000521	0.00295	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00052	0.00295	CcSEcCtD
Enzalutamide—Fatigue—Tamoxifen—pancreatic cancer	0.00052	0.00295	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000515	0.00292	CcSEcCtD
Enzalutamide—Fatigue—Erlotinib—pancreatic cancer	0.000514	0.00292	CcSEcCtD
Enzalutamide—Infection—Sunitinib—pancreatic cancer	0.000513	0.00291	CcSEcCtD
Enzalutamide—Nervous system disorder—Sunitinib—pancreatic cancer	0.000506	0.00287	CcSEcCtD
Enzalutamide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000506	0.00287	CcSEcCtD
Enzalutamide—Back pain—Irinotecan—pancreatic cancer	0.000504	0.00286	CcSEcCtD
Enzalutamide—Skin disorder—Sunitinib—pancreatic cancer	0.000502	0.00285	CcSEcCtD
Enzalutamide—Back pain—Gemcitabine—pancreatic cancer	0.000491	0.00279	CcSEcCtD
Enzalutamide—Neutropenia—Docetaxel—pancreatic cancer	0.000483	0.00274	CcSEcCtD
Enzalutamide—Sepsis—Epirubicin—pancreatic cancer	0.000482	0.00274	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00047	0.00267	CcSEcCtD
Enzalutamide—Vertigo—Irinotecan—pancreatic cancer	0.000468	0.00266	CcSEcCtD
Enzalutamide—Insomnia—Sunitinib—pancreatic cancer	0.000467	0.00265	CcSEcCtD
Enzalutamide—Leukopenia—Irinotecan—pancreatic cancer	0.000466	0.00265	CcSEcCtD
Enzalutamide—Pneumonia—Docetaxel—pancreatic cancer	0.000464	0.00263	CcSEcCtD
Enzalutamide—Paraesthesia—Sunitinib—pancreatic cancer	0.000464	0.00263	CcSEcCtD
Enzalutamide—Infestation NOS—Docetaxel—pancreatic cancer	0.000461	0.00262	CcSEcCtD
Enzalutamide—Infestation—Docetaxel—pancreatic cancer	0.000461	0.00262	CcSEcCtD
Enzalutamide—Leukopenia—Gemcitabine—pancreatic cancer	0.000454	0.00258	CcSEcCtD
Enzalutamide—Hypertension—Irinotecan—pancreatic cancer	0.00045	0.00255	CcSEcCtD
Enzalutamide—Leukopenia—Fluorouracil—pancreatic cancer	0.000447	0.00253	CcSEcCtD
Enzalutamide—Sepsis—Doxorubicin—pancreatic cancer	0.000446	0.00253	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000446	0.00253	CcSEcCtD
Enzalutamide—Fatigue—Sunitinib—pancreatic cancer	0.000445	0.00253	CcSEcCtD
Enzalutamide—Hypertension—Gemcitabine—pancreatic cancer	0.000438	0.00249	CcSEcCtD
Enzalutamide—Epistaxis—Docetaxel—pancreatic cancer	0.000435	0.00247	CcSEcCtD
Enzalutamide—Asthenia—Tamoxifen—pancreatic cancer	0.000433	0.00245	CcSEcCtD
Enzalutamide—Convulsion—Fluorouracil—pancreatic cancer	0.000432	0.00245	CcSEcCtD
Enzalutamide—Arthralgia—Gemcitabine—pancreatic cancer	0.000432	0.00245	CcSEcCtD
Enzalutamide—Hot flush—Epirubicin—pancreatic cancer	0.000431	0.00245	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000429	0.00243	CcSEcCtD
Enzalutamide—Asthenia—Erlotinib—pancreatic cancer	0.000428	0.00243	CcSEcCtD
Enzalutamide—Menopausal symptoms—Epirubicin—pancreatic cancer	0.000428	0.00243	CcSEcCtD
Enzalutamide—Pruritus—Tamoxifen—pancreatic cancer	0.000427	0.00242	CcSEcCtD
Enzalutamide—Infection—Irinotecan—pancreatic cancer	0.000423	0.0024	CcSEcCtD
Enzalutamide—Pruritus—Erlotinib—pancreatic cancer	0.000422	0.00239	CcSEcCtD
Enzalutamide—Nervous system disorder—Irinotecan—pancreatic cancer	0.000417	0.00237	CcSEcCtD
Enzalutamide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000416	0.00236	CcSEcCtD
Enzalutamide—Rhinitis—Docetaxel—pancreatic cancer	0.000415	0.00235	CcSEcCtD
Enzalutamide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000412	0.00234	CcSEcCtD
Enzalutamide—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000412	0.00234	CcSEcCtD
Enzalutamide—Infection—Gemcitabine—pancreatic cancer	0.000412	0.00233	CcSEcCtD
Enzalutamide—Pharyngitis—Docetaxel—pancreatic cancer	0.000411	0.00233	CcSEcCtD
Enzalutamide—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000409	0.00232	CcSEcCtD
Enzalutamide—Diarrhoea—Erlotinib—pancreatic cancer	0.000408	0.00232	CcSEcCtD
Enzalutamide—Oedema peripheral—Docetaxel—pancreatic cancer	0.000408	0.00231	CcSEcCtD
Enzalutamide—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000407	0.00231	CcSEcCtD
Enzalutamide—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000406	0.0023	CcSEcCtD
Enzalutamide—Urethral disorder—Docetaxel—pancreatic cancer	0.000406	0.0023	CcSEcCtD
Enzalutamide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000406	0.0023	CcSEcCtD
Enzalutamide—Infection—Fluorouracil—pancreatic cancer	0.000405	0.0023	CcSEcCtD
Enzalutamide—Skin disorder—Gemcitabine—pancreatic cancer	0.000402	0.00228	CcSEcCtD
Enzalutamide—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000399	0.00227	CcSEcCtD
Enzalutamide—Hot flush—Doxorubicin—pancreatic cancer	0.000399	0.00226	CcSEcCtD
Enzalutamide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000399	0.00226	CcSEcCtD
Enzalutamide—Dizziness—Tamoxifen—pancreatic cancer	0.000399	0.00226	CcSEcCtD
Enzalutamide—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000396	0.00224	CcSEcCtD
Enzalutamide—Dizziness—Erlotinib—pancreatic cancer	0.000394	0.00224	CcSEcCtD
Enzalutamide—Insomnia—Irinotecan—pancreatic cancer	0.000385	0.00218	CcSEcCtD
Enzalutamide—Paraesthesia—Irinotecan—pancreatic cancer	0.000382	0.00217	CcSEcCtD
Enzalutamide—Headache—Tamoxifen—pancreatic cancer	0.000378	0.00214	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000377	0.00214	CcSEcCtD
Enzalutamide—Angiopathy—Docetaxel—pancreatic cancer	0.000375	0.00213	CcSEcCtD
Enzalutamide—Insomnia—Gemcitabine—pancreatic cancer	0.000375	0.00213	CcSEcCtD
Enzalutamide—Headache—Erlotinib—pancreatic cancer	0.000374	0.00212	CcSEcCtD
Enzalutamide—Paraesthesia—Gemcitabine—pancreatic cancer	0.000372	0.00211	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000371	0.00211	CcSEcCtD
Enzalutamide—Asthenia—Sunitinib—pancreatic cancer	0.00037	0.0021	CcSEcCtD
Enzalutamide—Dry skin—Epirubicin—pancreatic cancer	0.00037	0.0021	CcSEcCtD
Enzalutamide—Insomnia—Fluorouracil—pancreatic cancer	0.000368	0.00209	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000367	0.00208	CcSEcCtD
Enzalutamide—Fatigue—Irinotecan—pancreatic cancer	0.000367	0.00208	CcSEcCtD
Enzalutamide—Paraesthesia—Fluorouracil—pancreatic cancer	0.000366	0.00208	CcSEcCtD
Enzalutamide—Pruritus—Sunitinib—pancreatic cancer	0.000365	0.00207	CcSEcCtD
Enzalutamide—Mental disorder—Docetaxel—pancreatic cancer	0.000363	0.00206	CcSEcCtD
Enzalutamide—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000361	0.00205	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000358	0.00203	CcSEcCtD
Enzalutamide—Fatigue—Gemcitabine—pancreatic cancer	0.000357	0.00203	CcSEcCtD
Enzalutamide—Muscular weakness—Epirubicin—pancreatic cancer	0.000356	0.00202	CcSEcCtD
Enzalutamide—Diarrhoea—Sunitinib—pancreatic cancer	0.000353	0.002	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000352	0.002	CcSEcCtD
Enzalutamide—Back pain—Docetaxel—pancreatic cancer	0.000348	0.00198	CcSEcCtD
Enzalutamide—Dry skin—Doxorubicin—pancreatic cancer	0.000342	0.00194	CcSEcCtD
Enzalutamide—Dizziness—Sunitinib—pancreatic cancer	0.000341	0.00194	CcSEcCtD
Enzalutamide—Bronchitis—Epirubicin—pancreatic cancer	0.000335	0.0019	CcSEcCtD
Enzalutamide—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000334	0.00189	CcSEcCtD
Enzalutamide—Muscular weakness—Doxorubicin—pancreatic cancer	0.000329	0.00187	CcSEcCtD
Enzalutamide—Neutropenia—Epirubicin—pancreatic cancer	0.000326	0.00185	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000324	0.00184	CcSEcCtD
Enzalutamide—Headache—Sunitinib—pancreatic cancer	0.000323	0.00183	CcSEcCtD
Enzalutamide—Leukopenia—Docetaxel—pancreatic cancer	0.000322	0.00183	CcSEcCtD
Enzalutamide—Pollakiuria—Epirubicin—pancreatic cancer	0.000322	0.00183	CcSEcCtD
Enzalutamide—Pneumonia—Epirubicin—pancreatic cancer	0.000313	0.00177	CcSEcCtD
Enzalutamide—Convulsion—Docetaxel—pancreatic cancer	0.000312	0.00177	CcSEcCtD
Enzalutamide—Hypertension—Docetaxel—pancreatic cancer	0.000311	0.00176	CcSEcCtD
Enzalutamide—Infestation—Epirubicin—pancreatic cancer	0.000311	0.00176	CcSEcCtD
Enzalutamide—Infestation NOS—Epirubicin—pancreatic cancer	0.000311	0.00176	CcSEcCtD
Enzalutamide—Bronchitis—Doxorubicin—pancreatic cancer	0.00031	0.00176	CcSEcCtD
Enzalutamide—Arthralgia—Docetaxel—pancreatic cancer	0.000307	0.00174	CcSEcCtD
Enzalutamide—Asthenia—Irinotecan—pancreatic cancer	0.000305	0.00173	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000305	0.00173	CcSEcCtD
Enzalutamide—Neutropenia—Doxorubicin—pancreatic cancer	0.000302	0.00171	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.0003	0.0017	CcSEcCtD
Enzalutamide—Pollakiuria—Doxorubicin—pancreatic cancer	0.000298	0.00169	CcSEcCtD
Enzalutamide—Asthenia—Gemcitabine—pancreatic cancer	0.000297	0.00169	CcSEcCtD
Enzalutamide—Haematuria—Epirubicin—pancreatic cancer	0.000296	0.00168	CcSEcCtD
Enzalutamide—Epistaxis—Epirubicin—pancreatic cancer	0.000293	0.00166	CcSEcCtD
Enzalutamide—Pruritus—Gemcitabine—pancreatic cancer	0.000293	0.00166	CcSEcCtD
Enzalutamide—Infection—Docetaxel—pancreatic cancer	0.000292	0.00166	CcSEcCtD
Enzalutamide—Sinusitis—Epirubicin—pancreatic cancer	0.000292	0.00165	CcSEcCtD
Enzalutamide—Diarrhoea—Irinotecan—pancreatic cancer	0.000291	0.00165	CcSEcCtD
Enzalutamide—Pneumonia—Doxorubicin—pancreatic cancer	0.000289	0.00164	CcSEcCtD
Enzalutamide—Nervous system disorder—Docetaxel—pancreatic cancer	0.000288	0.00164	CcSEcCtD
Enzalutamide—Pruritus—Fluorouracil—pancreatic cancer	0.000288	0.00163	CcSEcCtD
Enzalutamide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000288	0.00163	CcSEcCtD
Enzalutamide—Infestation—Doxorubicin—pancreatic cancer	0.000288	0.00163	CcSEcCtD
Enzalutamide—Infestation NOS—Doxorubicin—pancreatic cancer	0.000288	0.00163	CcSEcCtD
Enzalutamide—Skin disorder—Docetaxel—pancreatic cancer	0.000286	0.00162	CcSEcCtD
Enzalutamide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000283	0.00161	CcSEcCtD
Enzalutamide—Dizziness—Irinotecan—pancreatic cancer	0.000281	0.0016	CcSEcCtD
Enzalutamide—Rhinitis—Epirubicin—pancreatic cancer	0.00028	0.00159	CcSEcCtD
Enzalutamide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000279	0.00158	CcSEcCtD
Enzalutamide—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000278	0.00158	CcSEcCtD
Enzalutamide—Pharyngitis—Epirubicin—pancreatic cancer	0.000277	0.00157	CcSEcCtD
Enzalutamide—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000276	0.00156	CcSEcCtD
Enzalutamide—Oedema peripheral—Epirubicin—pancreatic cancer	0.000275	0.00156	CcSEcCtD
Enzalutamide—Haematuria—Doxorubicin—pancreatic cancer	0.000274	0.00156	CcSEcCtD
Enzalutamide—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000274	0.00156	CcSEcCtD
Enzalutamide—Urethral disorder—Epirubicin—pancreatic cancer	0.000274	0.00155	CcSEcCtD
Enzalutamide—Epistaxis—Doxorubicin—pancreatic cancer	0.000271	0.00154	CcSEcCtD
Enzalutamide—Sinusitis—Doxorubicin—pancreatic cancer	0.00027	0.00153	CcSEcCtD
Enzalutamide—Dizziness—Fluorouracil—pancreatic cancer	0.000269	0.00153	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000268	0.00152	CcSEcCtD
Enzalutamide—Headache—Irinotecan—pancreatic cancer	0.000266	0.00151	CcSEcCtD
Enzalutamide—Insomnia—Docetaxel—pancreatic cancer	0.000266	0.00151	CcSEcCtD
Enzalutamide—Paraesthesia—Docetaxel—pancreatic cancer	0.000264	0.0015	CcSEcCtD
Enzalutamide—Headache—Gemcitabine—pancreatic cancer	0.00026	0.00147	CcSEcCtD
Enzalutamide—Rhinitis—Doxorubicin—pancreatic cancer	0.000259	0.00147	CcSEcCtD
Enzalutamide—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000257	0.00146	CcSEcCtD
Enzalutamide—Pharyngitis—Doxorubicin—pancreatic cancer	0.000256	0.00145	CcSEcCtD
Enzalutamide—Headache—Fluorouracil—pancreatic cancer	0.000255	0.00145	CcSEcCtD
Enzalutamide—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000255	0.00145	CcSEcCtD
Enzalutamide—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000254	0.00144	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000254	0.00144	CcSEcCtD
Enzalutamide—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000254	0.00144	CcSEcCtD
Enzalutamide—Fatigue—Docetaxel—pancreatic cancer	0.000253	0.00144	CcSEcCtD
Enzalutamide—Angiopathy—Epirubicin—pancreatic cancer	0.000253	0.00144	CcSEcCtD
Enzalutamide—Urethral disorder—Doxorubicin—pancreatic cancer	0.000253	0.00144	CcSEcCtD
Enzalutamide—Mental disorder—Epirubicin—pancreatic cancer	0.000245	0.00139	CcSEcCtD
Enzalutamide—Back pain—Epirubicin—pancreatic cancer	0.000235	0.00133	CcSEcCtD
Enzalutamide—Angiopathy—Doxorubicin—pancreatic cancer	0.000234	0.00133	CcSEcCtD
Enzalutamide—Mental disorder—Doxorubicin—pancreatic cancer	0.000226	0.00128	CcSEcCtD
Enzalutamide—Vertigo—Epirubicin—pancreatic cancer	0.000218	0.00124	CcSEcCtD
Enzalutamide—Leukopenia—Epirubicin—pancreatic cancer	0.000217	0.00123	CcSEcCtD
Enzalutamide—Back pain—Doxorubicin—pancreatic cancer	0.000217	0.00123	CcSEcCtD
Enzalutamide—Asthenia—Docetaxel—pancreatic cancer	0.000211	0.0012	CcSEcCtD
Enzalutamide—Convulsion—Epirubicin—pancreatic cancer	0.000211	0.00119	CcSEcCtD
Enzalutamide—Hypertension—Epirubicin—pancreatic cancer	0.00021	0.00119	CcSEcCtD
Enzalutamide—Pruritus—Docetaxel—pancreatic cancer	0.000208	0.00118	CcSEcCtD
Enzalutamide—Arthralgia—Epirubicin—pancreatic cancer	0.000207	0.00117	CcSEcCtD
Enzalutamide—Anxiety—Epirubicin—pancreatic cancer	0.000206	0.00117	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000205	0.00117	CcSEcCtD
Enzalutamide—Vertigo—Doxorubicin—pancreatic cancer	0.000202	0.00115	CcSEcCtD
Enzalutamide—Leukopenia—Doxorubicin—pancreatic cancer	0.000201	0.00114	CcSEcCtD
Enzalutamide—Diarrhoea—Docetaxel—pancreatic cancer	0.000201	0.00114	CcSEcCtD
Enzalutamide—Infection—Epirubicin—pancreatic cancer	0.000197	0.00112	CcSEcCtD
Enzalutamide—Convulsion—Doxorubicin—pancreatic cancer	0.000195	0.00111	CcSEcCtD
Enzalutamide—Nervous system disorder—Epirubicin—pancreatic cancer	0.000194	0.0011	CcSEcCtD
Enzalutamide—Dizziness—Docetaxel—pancreatic cancer	0.000194	0.0011	CcSEcCtD
Enzalutamide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000194	0.0011	CcSEcCtD
Enzalutamide—Hypertension—Doxorubicin—pancreatic cancer	0.000194	0.0011	CcSEcCtD
Enzalutamide—Skin disorder—Epirubicin—pancreatic cancer	0.000193	0.00109	CcSEcCtD
Enzalutamide—Arthralgia—Doxorubicin—pancreatic cancer	0.000191	0.00109	CcSEcCtD
Enzalutamide—Anxiety—Doxorubicin—pancreatic cancer	0.000191	0.00108	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00019	0.00108	CcSEcCtD
Enzalutamide—Headache—Docetaxel—pancreatic cancer	0.000184	0.00104	CcSEcCtD
Enzalutamide—Infection—Doxorubicin—pancreatic cancer	0.000182	0.00103	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000181	0.00102	CcSEcCtD
Enzalutamide—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00018	0.00102	CcSEcCtD
Enzalutamide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00018	0.00102	CcSEcCtD
Enzalutamide—Insomnia—Epirubicin—pancreatic cancer	0.000179	0.00102	CcSEcCtD
Enzalutamide—Skin disorder—Doxorubicin—pancreatic cancer	0.000178	0.00101	CcSEcCtD
Enzalutamide—Paraesthesia—Epirubicin—pancreatic cancer	0.000178	0.00101	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000171	0.000971	CcSEcCtD
Enzalutamide—Fatigue—Epirubicin—pancreatic cancer	0.000171	0.00097	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000167	0.000948	CcSEcCtD
Enzalutamide—Insomnia—Doxorubicin—pancreatic cancer	0.000166	0.000941	CcSEcCtD
Enzalutamide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000165	0.000935	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000158	0.000899	CcSEcCtD
Enzalutamide—Fatigue—Doxorubicin—pancreatic cancer	0.000158	0.000897	CcSEcCtD
Enzalutamide—Asthenia—Epirubicin—pancreatic cancer	0.000142	0.000807	CcSEcCtD
Enzalutamide—Pruritus—Epirubicin—pancreatic cancer	0.00014	0.000796	CcSEcCtD
Enzalutamide—Diarrhoea—Epirubicin—pancreatic cancer	0.000136	0.00077	CcSEcCtD
Enzalutamide—Asthenia—Doxorubicin—pancreatic cancer	0.000132	0.000747	CcSEcCtD
Enzalutamide—Dizziness—Epirubicin—pancreatic cancer	0.000131	0.000744	CcSEcCtD
Enzalutamide—Pruritus—Doxorubicin—pancreatic cancer	0.00013	0.000736	CcSEcCtD
Enzalutamide—Diarrhoea—Doxorubicin—pancreatic cancer	0.000126	0.000712	CcSEcCtD
Enzalutamide—Headache—Epirubicin—pancreatic cancer	0.000124	0.000705	CcSEcCtD
Enzalutamide—Dizziness—Doxorubicin—pancreatic cancer	0.000121	0.000688	CcSEcCtD
Enzalutamide—Headache—Doxorubicin—pancreatic cancer	0.000115	0.000652	CcSEcCtD
Enzalutamide—CYP3A5—Metabolism—PRSS1—pancreatic cancer	1.11e-05	0.00101	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.06e-05	0.000969	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—CD44—pancreatic cancer	1.04e-05	0.000952	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.02e-05	0.000932	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.01e-05	0.000924	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	1.01e-05	0.000924	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IFNA1—pancreatic cancer	1.01e-05	0.000922	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ARG2—pancreatic cancer	9.82e-06	0.0009	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ARG2—pancreatic cancer	9.59e-06	0.00088	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PRSS1—pancreatic cancer	9.58e-06	0.000879	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PRSS1—pancreatic cancer	9.53e-06	0.000874	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IFNA2—pancreatic cancer	9.36e-06	0.000858	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—SMAD4—pancreatic cancer	9.19e-06	0.000842	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	8.78e-06	0.000805	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—TYMP—pancreatic cancer	8.58e-06	0.000787	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	8.57e-06	0.000786	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PRSS1—pancreatic cancer	8.56e-06	0.000785	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—TYMP—pancreatic cancer	8.39e-06	0.000769	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PRSS1—pancreatic cancer	8.35e-06	0.000766	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ARG2—pancreatic cancer	8.31e-06	0.000762	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ARG2—pancreatic cancer	8.26e-06	0.000758	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	7.95e-06	0.000729	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PRSS1—pancreatic cancer	7.87e-06	0.000722	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PRSS1—pancreatic cancer	7.8e-06	0.000715	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	7.74e-06	0.00071	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	7.67e-06	0.000703	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—MYC—pancreatic cancer	7.57e-06	0.000694	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	7.47e-06	0.000685	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ARG2—pancreatic cancer	7.42e-06	0.00068	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—TYMP—pancreatic cancer	7.26e-06	0.000666	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ARG2—pancreatic cancer	7.24e-06	0.000664	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—TYMP—pancreatic cancer	7.22e-06	0.000662	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	7.04e-06	0.000645	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	6.93e-06	0.000635	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GLP1R—pancreatic cancer	6.92e-06	0.000634	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	6.86e-06	0.000629	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ARG2—pancreatic cancer	6.82e-06	0.000626	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—DPYD—pancreatic cancer	6.8e-06	0.000624	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—NOTCH1—pancreatic cancer	6.77e-06	0.000621	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ARG2—pancreatic cancer	6.76e-06	0.00062	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GLP1R—pancreatic cancer	6.76e-06	0.00062	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	6.75e-06	0.000619	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—DPYD—pancreatic cancer	6.65e-06	0.00061	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PLAU—pancreatic cancer	6.64e-06	0.000609	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—TYMP—pancreatic cancer	6.48e-06	0.000595	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	6.46e-06	0.000592	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—PPARG—pancreatic cancer	6.39e-06	0.000586	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—TYMP—pancreatic cancer	6.33e-06	0.00058	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	6.31e-06	0.000579	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	6.29e-06	0.000577	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	6.21e-06	0.000569	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	6.2e-06	0.000568	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	6.07e-06	0.000557	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.99e-06	0.00055	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—TYMP—pancreatic cancer	5.96e-06	0.000547	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.96e-06	0.000547	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—TYMP—pancreatic cancer	5.91e-06	0.000542	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CG—pancreatic cancer	5.91e-06	0.000542	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GLP1R—pancreatic cancer	5.86e-06	0.000537	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—EGF—pancreatic cancer	5.84e-06	0.000536	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GLP1R—pancreatic cancer	5.82e-06	0.000534	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	5.78e-06	0.00053	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—DPYD—pancreatic cancer	5.76e-06	0.000528	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	5.74e-06	0.000526	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—DPYD—pancreatic cancer	5.73e-06	0.000525	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	5.47e-06	0.000501	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—SLC2A2—pancreatic cancer	5.44e-06	0.000498	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.41e-06	0.000496	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.38e-06	0.000493	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	5.35e-06	0.000491	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.35e-06	0.000491	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	5.27e-06	0.000483	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GLP1R—pancreatic cancer	5.23e-06	0.000479	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.22e-06	0.000479	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CD—pancreatic cancer	5.19e-06	0.000476	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.19e-06	0.000476	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PRSS1—pancreatic cancer	5.14e-06	0.000472	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—DPYD—pancreatic cancer	5.14e-06	0.000471	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GLP1R—pancreatic cancer	5.1e-06	0.000468	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	5.1e-06	0.000468	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—DPYD—pancreatic cancer	5.02e-06	0.00046	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CD44—pancreatic cancer	5e-06	0.000459	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CD44—pancreatic cancer	4.89e-06	0.000448	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	4.88e-06	0.000447	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.88e-06	0.000447	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.83e-06	0.000443	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GLP1R—pancreatic cancer	4.81e-06	0.000441	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GCG—pancreatic cancer	4.79e-06	0.00044	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GLP1R—pancreatic cancer	4.77e-06	0.000437	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SLC2A2—pancreatic cancer	4.76e-06	0.000437	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.76e-06	0.000436	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—DPYD—pancreatic cancer	4.73e-06	0.000434	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.73e-06	0.000434	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—DPYD—pancreatic cancer	4.69e-06	0.00043	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GCG—pancreatic cancer	4.69e-06	0.00043	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.66e-06	0.000427	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CB—pancreatic cancer	4.53e-06	0.000415	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—STK11—pancreatic cancer	4.51e-06	0.000413	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	4.49e-06	0.000412	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ARG2—pancreatic cancer	4.46e-06	0.000409	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	4.45e-06	0.000408	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—STK11—pancreatic cancer	4.41e-06	0.000404	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.4e-06	0.000404	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	4.37e-06	0.000401	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.31e-06	0.000395	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.25e-06	0.00039	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.24e-06	0.000389	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CD44—pancreatic cancer	4.23e-06	0.000388	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CD44—pancreatic cancer	4.21e-06	0.000386	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.15e-06	0.00038	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.12e-06	0.000378	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.11e-06	0.000377	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.08e-06	0.000374	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GCG—pancreatic cancer	4.06e-06	0.000372	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GCG—pancreatic cancer	4.04e-06	0.00037	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.9e-06	0.000358	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—TYMS—pancreatic cancer	3.88e-06	0.000356	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.87e-06	0.000355	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—STK11—pancreatic cancer	3.82e-06	0.00035	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—STK11—pancreatic cancer	3.79e-06	0.000348	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—TYMS—pancreatic cancer	3.79e-06	0.000348	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CD44—pancreatic cancer	3.78e-06	0.000346	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.7e-06	0.000339	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CD44—pancreatic cancer	3.69e-06	0.000338	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.67e-06	0.000336	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MYC—pancreatic cancer	3.64e-06	0.000334	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SRC—pancreatic cancer	3.63e-06	0.000333	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GCG—pancreatic cancer	3.62e-06	0.000332	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.58e-06	0.000328	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.56e-06	0.000327	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GCG—pancreatic cancer	3.54e-06	0.000324	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—pancreatic cancer	3.53e-06	0.000324	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—NRAS—pancreatic cancer	3.49e-06	0.00032	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CD44—pancreatic cancer	3.48e-06	0.000319	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CD44—pancreatic cancer	3.45e-06	0.000316	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—STK11—pancreatic cancer	3.41e-06	0.000312	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.37e-06	0.000309	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.34e-06	0.000307	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GCG—pancreatic cancer	3.33e-06	0.000306	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—STK11—pancreatic cancer	3.32e-06	0.000305	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GCG—pancreatic cancer	3.3e-06	0.000303	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—TYMS—pancreatic cancer	3.28e-06	0.000301	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—TYMS—pancreatic cancer	3.26e-06	0.000299	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB1—pancreatic cancer	3.24e-06	0.000297	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.2e-06	0.000293	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOE—pancreatic cancer	3.15e-06	0.000289	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.14e-06	0.000288	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—STK11—pancreatic cancer	3.13e-06	0.000287	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—STK11—pancreatic cancer	3.11e-06	0.000285	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.09e-06	0.000284	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOE—pancreatic cancer	3.08e-06	0.000283	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—KRAS—pancreatic cancer	3e-06	0.000275	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.93e-06	0.000269	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—TYMS—pancreatic cancer	2.93e-06	0.000269	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.92e-06	0.000267	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—TYMS—pancreatic cancer	2.86e-06	0.000262	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	2.85e-06	0.000261	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	2.78e-06	0.000255	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CA—pancreatic cancer	2.76e-06	0.000253	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARG—pancreatic cancer	2.75e-06	0.000252	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.69e-06	0.000247	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARG—pancreatic cancer	2.68e-06	0.000246	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—TYMS—pancreatic cancer	2.67e-06	0.000245	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—pancreatic cancer	2.67e-06	0.000245	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOE—pancreatic cancer	2.67e-06	0.000245	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOE—pancreatic cancer	2.65e-06	0.000243	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—HRAS—pancreatic cancer	2.55e-06	0.000234	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—AKT1—pancreatic cancer	2.53e-06	0.000232	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.53e-06	0.000232	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.51e-06	0.00023	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	2.5e-06	0.000229	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	2.45e-06	0.000224	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	2.41e-06	0.000221	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CG—pancreatic cancer	2.4e-06	0.00022	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOE—pancreatic cancer	2.38e-06	0.000218	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOE—pancreatic cancer	2.33e-06	0.000213	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.33e-06	0.000213	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARG—pancreatic cancer	2.31e-06	0.000212	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CD44—pancreatic cancer	2.27e-06	0.000208	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.26e-06	0.000207	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—AKT1—pancreatic cancer	2.25e-06	0.000207	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOE—pancreatic cancer	2.19e-06	0.000201	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	2.18e-06	0.0002	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GCG—pancreatic cancer	2.18e-06	0.0002	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOE—pancreatic cancer	2.17e-06	0.000199	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—pancreatic cancer	2.16e-06	0.000198	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.15e-06	0.000197	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	2.13e-06	0.000195	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.12e-06	0.000194	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—pancreatic cancer	2.11e-06	0.000194	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CD—pancreatic cancer	2.11e-06	0.000193	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.1e-06	0.000192	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.08e-06	0.00019	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.06e-06	0.000189	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—STK11—pancreatic cancer	2.05e-06	0.000188	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARG—pancreatic cancer	2.03e-06	0.000186	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.98e-06	0.000181	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	1.96e-06	0.00018	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.91e-06	0.000175	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARG—pancreatic cancer	1.89e-06	0.000174	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.89e-06	0.000173	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTEN—pancreatic cancer	1.88e-06	0.000173	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	1.85e-06	0.000169	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.85e-06	0.000169	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTEN—pancreatic cancer	1.84e-06	0.000169	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CB—pancreatic cancer	1.84e-06	0.000168	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—pancreatic cancer	1.83e-06	0.000168	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—pancreatic cancer	1.82e-06	0.000167	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.76e-06	0.000162	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.74e-06	0.000159	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.72e-06	0.000158	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.65e-06	0.000151	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.63e-06	0.00015	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.61e-06	0.000147	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.6e-06	0.000146	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.59e-06	0.000146	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTEN—pancreatic cancer	1.59e-06	0.000145	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.52e-06	0.000139	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.5e-06	0.000138	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.5e-06	0.000138	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.49e-06	0.000137	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOE—pancreatic cancer	1.43e-06	0.000131	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.42e-06	0.000131	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTEN—pancreatic cancer	1.39e-06	0.000127	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	1.33e-06	0.000122	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.31e-06	0.00012	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	1.3e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.3e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.29e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.25e-06	0.000114	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.14e-06	0.000104	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.13e-06	0.000103	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CA—pancreatic cancer	1.12e-06	0.000103	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKT1—pancreatic cancer	1.09e-06	9.96e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.06e-06	9.73e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1e-06	9.21e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	9.91e-07	9.09e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	9.82e-07	9e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CA—pancreatic cancer	9.8e-07	8.99e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	9.24e-07	8.47e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKT1—pancreatic cancer	9.19e-07	8.43e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	9.16e-07	8.4e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKT1—pancreatic cancer	9.14e-07	8.38e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTEN—pancreatic cancer	8.56e-07	7.85e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKT1—pancreatic cancer	8.21e-07	7.52e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKT1—pancreatic cancer	8.01e-07	7.34e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKT1—pancreatic cancer	7.55e-07	6.92e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKT1—pancreatic cancer	7.48e-07	6.86e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	6.04e-07	5.54e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.93e-07	4.52e-05	CbGpPWpGaD
